Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?

Acta Otolaryngol. 2006 Dec;126(11):1225-8. doi: 10.1080/00016480600818088.

Abstract

Conclusion: A complete clinical and radiological response observed following chemotherapy and radiotherapy is not predictive of the absence of residual disease. Moreover, salvage neck surgery does not always seem to be an effective strategy. Consequently, early neck dissection should be advised for patients with complete clinical and radiological response (CCRR) after chemoradiotherapy for tumors with N2-N3 disease.

Background: We retrospectively reviewed the outcome of 28 patients with N2-N3 disease treated initially with chemotherapy and radiotherapy.

Patients and methods: A neck dissection was performed for all patients with residual disease in the neck.

Results: A CCRR in the neck was achieved in 25 of 28 patients. The remaining three patients with residual neck mass underwent a salvage neck dissection: the pathological examination confirmed the persistence of tumoral disease. No regional failure was observed in these three patients. In 25 patients considered to have CCRR in the neck, 5 patients (20%) developed regional recurrence. Successful salvage approach was not possible for any of these patients.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / administration & dosage
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / radiotherapy*
  • Cisplatin / administration & dosage
  • Cobalt Radioisotopes / therapeutic use
  • Combined Modality Therapy
  • Dose Fractionation, Radiation
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Neck Dissection
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Staging
  • Neoplasm, Residual / diagnosis*
  • Otorhinolaryngologic Neoplasms / diagnosis
  • Otorhinolaryngologic Neoplasms / drug therapy*
  • Otorhinolaryngologic Neoplasms / pathology
  • Otorhinolaryngologic Neoplasms / radiotherapy*
  • Prognosis
  • Radioisotope Teletherapy
  • Retrospective Studies
  • Salvage Therapy
  • Tomography, X-Ray Computed*

Substances

  • Cobalt Radioisotopes
  • Carboplatin
  • Cisplatin
  • Fluorouracil